Who is sponsoring NCT05515419?

NCT05515419 is sponsored by The Medical Pavilion Bahamas.

What drugs are being tested in NCT05515419?

Interventions in NCT05515419: Allogeneic cord blood treatment.

What condition does NCT05515419 study?

NCT05515419 studies Neurological Diseases, Stroke, Spinal Cord Injuries.

Is NCT05515419 still recruiting?

NCT05515419 is currently withdrawn. Last updated 10 September 2025.

Last reviewed 2025-09-10 · How we verify

NCT05515419

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Allogeneic Cord Blood for Neurological Diseases in Adults

Withdrawn EARLY_PHASE1 Last updated 10 September 2025

What this trial tests

EARLY_PHASE1 trial testing Allogeneic cord blood treatment in Neurological Diseases. Withdrawn.

Timeline

1 July 2025

Primary endpoint
30 September 2026

30 November 2026

Quick facts

Lead sponsor	The Medical Pavilion Bahamas
Phase	EARLY_PHASE1
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Start date	1 July 2025
Primary completion	30 September 2026
Estimated completion	30 November 2026

Drugs / interventions tested

Allogeneic cord blood treatment — full drug profile →

Conditions studied

Neurological Diseases — all drugs for Neurological Diseases →
Stroke — all drugs for Stroke →
Spinal Cord Injuries — all drugs for Spinal Cord Injuries →

Sponsor

The Medical Pavilion Bahamas — full company profile →

Who can join

18 and older, any sex, with Neurological Diseases or Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This open label trial is conducted to investigate the efficacy and safety of allogeneic umbilical cord blood therapy for adult patients with neurological diseases.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05515419 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Medical Pavilion Bahamas
Last refreshed: 10 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05515419.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing